- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
Unpacking the Latest Options Trading Trends in Merck & Co
January 07, 2025
Tickers
MRK
From Benzinga
From Benzinga
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
From Benzinga
Why Viking Therapeutics Stock Plummeted by 24% in December
January 04, 2025
From Motley Fool
Should You Buy the Dip on This High-Flying Stock?
January 03, 2025
From Motley Fool
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
January 02, 2025
From Benzinga
From Benzinga
2 High-Yield Dividend Stocks to Buy Early in 2025
December 31, 2024
From Motley Fool
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
December 30, 2024
From Motley Fool
3 Stocks That Could Be Monster Winners in 2025
December 29, 2024
From Motley Fool
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
December 25, 2024
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
From Benzinga
Is Merck the Next Big Weight-Loss Stock?
December 22, 2024
From Motley Fool
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
December 21, 2024
From Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
December 20, 2024
From Motley Fool
Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks
December 20, 2024
From Motley Fool
3 Stocks That Could Turn $1,000 into $5,000 by 2030
December 20, 2024
From Motley Fool
Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
December 19, 2024
From Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
From Benzinga
Stock Of The Day: Where Does The Merck Downtrend End?
December 19, 2024
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
From Benzinga
What's Going On With Viking Therapeutics Stock On Wednesday?
December 18, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 18, 2024
From Benzinga
What's Going On With Merck Shares Wednesday?
December 18, 2024
From Benzinga
From Benzinga
From Benzinga
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
December 13, 2024
From Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
December 12, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.